<DOC>
	<DOC>NCT00349180</DOC>
	<brief_summary>This study is performed to confirm the optimal dose for THR (total hip replacement).</brief_summary>
	<brief_title>Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)</brief_title>
	<detailed_description />
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Patients undergoing elective primary THR (total hip replacement) surgery Patient with risk of clinical significant bleeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Total Hip Replacement</keyword>
	<keyword>Enoxaparin</keyword>
</DOC>